- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05897710
Virtual World-Based Cardiac Rehabilitation (VWCR)
February 24, 2026 updated by: LaPrincess C. Brewer, Mayo Clinic
Virtual World-Based Cardiac Rehabilitation to Improve Cardiovascular Health and Outcomes Among Cardiac Patients
The proposed trial is a multiphase, multicenter, non-inferiority, hybrid type 1 effectiveness, randomized controlled trial to test an innovative virtual world-based cardiac rehabilitation (CR) program, "Destination Cardiac Rehab".
The primary objectives of this study are to assess the efficacy and adherence of "Destination Cardiac Rehab" compared to traditional center-based CR.
Study Overview
Status
Completed
Conditions
Detailed Description
The proposed virtual world-based cardiac rehabilitation (VWCR) program provides a novel home-based delivery method of a CR program to address several barriers to care associated with traditional center-based CR (CBCR).
This 2-arm, randomized controlled trial (RCT) will rigorously assess adherence and efficacy of VWCR compared to CBCR in a 12-week (36-session) intervention that includes patient education, self-monitoring of physical activity and blood pressure, social support, and weekly telehealth visits with a CR nurse and exercise physiologist.
Patients with a CR eligible cardiovascular event will be recruited from 6 geographically diverse CR centers across the United States.
We hypothesize that the VWCR, known as "Destination Cardiac Rehab" will be non-inferior to CBCR as assessed by improvement in cardiovascular health and adherence to CR sessions.
Study Type
Interventional
Enrollment (Actual)
2881
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Minnesota
-
Rochester, Minnesota, United States, 55905
- Mayo Clinic
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Yes
Description
Inclusion Criteria:
- Indication for CR according to Centers for Medicare & Medicaid Services (CMS) guidelines: Myocardial infarction within the preceding 12 months; Coronary artery bypass surgery; Current stable angina (chest pain); Heart valve repair or replacement; Percutaneous transluminal coronary angioplasty (PTCA) or coronary stenting; Heart or heart-lung transplant; Stable chronic heart failure
- Aged ≥18 years
- Basic Internet navigation skills
- Active email address
Exclusion Criteria:
- High risk patients according to the American Association of Cardiovascular and Pulmonary Rehabilitation (AACVPR) risk stratification (e.g., sudden cardiac arrest survivor)
- Receiving continuous inotropic support
- Presence of a mechanical circulatory support device
- Decompensated heart failure
- Symptomatic valvular heart disease
- Uncontrolled angina
- Presence of hemodynamically unstable dysrhythmias (e.g., ventricular tachycardia) given safety concern of unsupervised exercise20
- Pregnant (due to associated hormonal and weight changes)
- Non-English-speaking
- Visual/hearing impairment or mental disability that would preclude independent use of the VW platform
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Health Services Research
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Active Comparator: Center-Based Cardiac Rehab (CBCR)
Standard of care for participants' center-based cardiac rehabilitation program.
Traditional 12-week, in-person program.
|
Traditional 12-week in-person cardiac rehabilitation program; standard of care at participant's cardiac rehabilitation facility
|
|
Experimental: Virtual World-Based Cardiac Rehab (VWCR)
Telehealth delivery of cardiac rehabilitation via Second Life virtual world platform.
12-week, home-based program.
|
12-week virtual world technology-based program via Second Life platform.
Weekly virtual visits with nurse coach and exercise physiologist, weekly education sessions, and social support group discussions within the virtual world environment.
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Life's Essential 8 component: Self-reported healthy diet
Time Frame: Baseline, 3 months, and 6 months post-randomization
|
Changes from baseline in healthy diet using the Mediterranean Eating Patterns for Americans (MEPA), a 16-item questionnaire evaluating accordance with a Mediterranean-like diet pattern
|
Baseline, 3 months, and 6 months post-randomization
|
|
Life's Essential 8 component: Self-reported physical activity
Time Frame: Baseline, 3 months, and 6 months post-randomization
|
Changes from baseline in physical activity using the International Physical Activity Questionnaire (IPAQ), a 12-item questionnaire classifying physical activity as "low," "moderate," or "high" intensity physical activity (minutes/day) over the prior week
|
Baseline, 3 months, and 6 months post-randomization
|
|
Life's Essential 8 component: Self-Reported smoking status
Time Frame: Baseline, 3 months, and 6 months post-randomization
|
Changes from baseline in smoking status using the National Health and Nutrition Examination Survey-Smoking-Cigarette Use Questionnaire (NHANES-SMQ), evaluating current and past smoking habits
|
Baseline, 3 months, and 6 months post-randomization
|
|
Life's Essential 8 component: Sleep Quality
Time Frame: Baseline, 3 months, and 6 months post-randomization
|
Changes from baseline in sleep quality (number of hours of sleep nightly) using the Pittsburg Sleep Quality Index (PSQI).
|
Baseline, 3 months, and 6 months post-randomization
|
|
Life's Essential 8 component: Body Mass Index (BMI)
Time Frame: Baseline, 3 months, and 6 months post-randomization
|
Changes from baseline in BMI as calculated with weight (kg) and height (m), reported as kg/m^2
|
Baseline, 3 months, and 6 months post-randomization
|
|
Life's Essential 8 component: Cholesterol
Time Frame: Baseline, 3 months, and 6 months post-randomization
|
Changes from baseline in Non-HDL Cholesterol levels reported as mg/dL
|
Baseline, 3 months, and 6 months post-randomization
|
|
Life's Essential 8 component: Blood Glucose
Time Frame: Baseline, 3 months, and 6 months post-randomization
|
Changes from baseline in Hemoglobin A1c (percent) and fasting blood glucose (mg/dL)
|
Baseline, 3 months, and 6 months post-randomization
|
|
Life's Essential 8 component: Blood Pressure
Time Frame: Baseline, 3 months, and 6 months post-randomization
|
Changes from baseline in systolic and diastolic blood pressure measurements; average of three sitting readings in mmHg
|
Baseline, 3 months, and 6 months post-randomization
|
|
Life's Essential 8 composite score: Cardiovascular health
Time Frame: Baseline, 3 months, and 6 months post-randomization
|
Changes from baseline in Life's Essential 8 score.
Life's Essential 8 composite score is determined as a composite of all components by calculating an unweighted average score on a scale of 0 to 100 points.
An overall cardiovascular health score (Life's Essential 8 score) will be considered high (80 to 100 points), moderate (50 to 79 points) or low for (0 to 49 points).
|
Baseline, 3 months, and 6 months post-randomization
|
|
Number of sessions attended by participants
Time Frame: Baseline through 12-week program
|
Optimal adherence defined as completion of 70% or more of weekly visits (in-person or virtual).
Attendance measured by CR staff for control group, and by VWCR web administrators, Exercise Physiologists, and Nurse Coaches in the VWCR arm.
|
Baseline through 12-week program
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
MACE (Major Adverse Cardiovascular Events) 3 months post-randomization
Time Frame: 3 months and 6 months post-randomization
|
MACE (Major Adverse Cardiovascular Events): CV-related hospital readmissions; CV and all-cause mortality
|
3 months and 6 months post-randomization
|
|
Exercise Sessions
Time Frame: Baseline through 12-week (36 session) cardiac rehabilitation program
|
Self-reported number of self-directed exercise sessions per week, confirmed by Fitbit activity tracker data.
|
Baseline through 12-week (36 session) cardiac rehabilitation program
|
|
Functional Capacity
Time Frame: Baseline, 3 months, and 6 months post-randomization
|
Six-Minute walk test, evaluating blood pressure, oxygen saturation, and pulse after walking for 6 minutes at a normal pace
|
Baseline, 3 months, and 6 months post-randomization
|
|
Health-related quality of life
Time Frame: Baseline, 3 months, and 6 months post-randomization
|
Changes from baseline in health-related quality of life using the Short Form [SF]-12 Health Survey, a self-reported outcome measure assessing the impact of health on an individual's everyday life.
The SF-12 consists of 12-items and 8 subdomains.
Each item of the questionnaire has response categories which vary from 2- to 6-point scales and raw scores for items ranging from 1 to 6.
The raw scores are summated and linearly transformed into 0-100 scale with a higher score indicating better health status.
|
Baseline, 3 months, and 6 months post-randomization
|
|
Physical Activity Self-efficacy
Time Frame: Baseline, 3 months, and 6 months post-randomization
|
Changes from baseline in physical activity self-efficacy measured by the Exercise Confidence Survey scale to assess the participant's confidence in their ability to exercise when faced with common barriers.
12 items are assessed, each on a 5-point scale ranging from 1 to 5. A higher total sum indicates higher self-efficacy for physical activity.
|
Baseline, 3 months, and 6 months post-randomization
|
|
Physical Activity Self-regulation
Time Frame: Baseline, 3 months, and 6 months post-randomization
|
Changes from baseline in physical activity self-regulation measured by the Health Beliefs Survey to assess strategies used in the past 3 months to increase their step count or physical activity levels.
Items are measured on a five-point scale from 1 (never) to 5 (repeatedly).
Higher scores indicate more self-regulation.
|
Baseline, 3 months, and 6 months post-randomization
|
|
Physical Activity Social Support
Time Frame: Baseline, 3 months, and 6 months post-randomization
|
Changes from baseline in physical activity social support using the Social Support for Exercise Survey scale that asks participants how much encouragement they received to increase physical activity on a five-point scale from 1 (never) to 5 (very often).
Higher scores indicate more social support for physical activity.
|
Baseline, 3 months, and 6 months post-randomization
|
|
Diet Self-efficacy
Time Frame: Baseline, 3 months, and 6 months post-randomization
|
Changes from baseline in diet self-efficacy measured the Diet Confidence Survey scale to assess the participant's confidence in their ability to maintain a healthy diet when faced with common barriers.
12 items are assessed, each on a 5-point scale ranging from 1 to 5. A higher total sum indicates higher self-efficacy for healthy eating.
|
Baseline, 3 months, and 6 months post-randomization
|
|
Diet Self-regulation
Time Frame: Baseline, 3 months, and 6 months post-randomization
|
Changes from baseline in diet self-regulation measured by the Health Beliefs Survey to assess strategies used in the past 3 months to eat healthier foods.
Items are measured on a five-point scale from 1 (never) to 5 (repeatedly).
Higher scores indicate more use of self-regulation strategies to promote healthy eating.
|
Baseline, 3 months, and 6 months post-randomization
|
|
Diet Social Support
Time Frame: Baseline, 3 months, and 6 months post-randomization
|
Changes from baseline in diet social support using the Social Support for Eating Habits Survey scale that asks participants how much encouragement they received to eat healthier on a five-point scale from 1 (never) to 5 (very often).
Higher scores indicate more social support for healthy eating.
|
Baseline, 3 months, and 6 months post-randomization
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Collaborators
Investigators
- Principal Investigator: LaPrincess Brewer, M.D., M.P.H., Mayo Clinic
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
March 7, 2023
Primary Completion (Actual)
January 31, 2024
Study Completion (Actual)
January 31, 2024
Study Registration Dates
First Submitted
May 5, 2023
First Submitted That Met QC Criteria
June 1, 2023
First Posted (Actual)
June 9, 2023
Study Record Updates
Last Update Posted (Actual)
February 27, 2026
Last Update Submitted That Met QC Criteria
February 24, 2026
Last Verified
February 1, 2026
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 22-011357
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Cardiovascular Diseases
-
Hull University Teaching Hospitals NHS TrustNot yet recruitingCardiovascular Surgery | Cardiovascular Diseases (CVD)United Kingdom
-
Weill Medical College of Cornell UniversityAmerican Heart AssociationRecruitingCardiovascular | Cardiovascular Health | Cardiovascular (CV) Risk | Cardiovascular Disease (CVD) Risk FactorsUnited States
-
Fu Jen Catholic UniversityRecruitingCardiovascular Disease | Cardiovascular SurgeryTaiwan
-
Medical College of WisconsinNational Center for Complementary and Integrative Health (NCCIH)CompletedCardiovascular Diseases | Cardiovascular Risk Factor | Cardiovascular HealthUnited States
-
Hospital Mutua de TerrassaCompleted
-
IRCCS Policlinico S. DonatoIRCCS San Raffaele; Fondazione Policlinico Universitario Agostino Gemelli IRCCS and other collaboratorsRecruitingCardiovascular Risk | Genetic Cardiovascular RiskItaly
-
Oregon Health and Science UniversityCompletedCardiovascular Disease | Cardiovascular Risk FactorsUnited States
-
Women's College HospitalUniversity Health Network, Toronto; Sunnybrook Health Sciences Centre; Brigham... and other collaboratorsUnknownCARDIOVASCULAR DISEASESCanada, United States
-
Groupe Hospitalier Paris Saint JosephTerminatedCARDIOVASCULAR DISEASESFrance
-
National Medical Research Center for Therapy and...BU "Respublikanski Kardiologicheski Dispanser" Minzdrava Chuvashii, CheboksaryCompletedMultimorbidity, Cardiovascular DiseasesRussian Federation
Clinical Trials on Center-Based Cardiac Rehabilitation (CBCR)
-
National University, SingaporeNational University Hospital, SingaporeRecruitingMyocardial InfarctionSingapore
-
Université de SherbrookeActive, not recruiting
-
Riphah International UniversityCompletedCoronary Heart DiseasePakistan
-
Kessler FoundationActive, not recruiting
-
KU LeuvenHasselt University; Jessa HospitalCompletedMyocardial Infarction | Coronary Artery Disease (CAD) (E.G., Angina, Myocardial Infarction, and Atherosclerotic Heart Disease (ASHD)) | Percutaneous Transluminal Cutting Balloon Angioplasty of Popliteal Vein Using Fluoroscopic GuidanceBelgium
-
Hanoi Medical UniversityNot yet recruitingValvular DiseasesVietnam
-
Bispebjerg HospitalGöteborg University; Rigshospitalet, Denmark; University of Basel; Aalborg University... and other collaboratorsRecruitingStroke | Parkinson Disease | Cognitive Dysfunction | Cardiac Arrest | Executive DysfunctionDenmark
-
Azienda Ospedaliero Universitaria di SassariCompletedHeart Failure | Cardiac RehabilitationItaly
-
ADIR AssociationEuropean Union; Hopital La Musse; Groupe Hospitalier du Havre; Centre Hospitalier... and other collaboratorsRecruitingChronic Obstructive Pulmonary Disease (COPD)France
-
Federico II UniversityCompletedAcute Myocardial InfarctionItaly